All In MedTech

Device Trial Radar · NCT06298981

Pulse Rate and Breathing Rate Accuracy

Pulse Rate and Breathing Rate Accuracy Study - NuraLogix AMC-SDK

Last checked: Nov 20, 2026Latest source record: Mar 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Feb 12, 2024

Primary completion

Jun 30, 2024

Study completion Jun 30, 2024

Sponsor

Lead sponsor
Nuralogix CorporationNot on our public-company list
Sponsor type
Industry
First posted
Mar 7, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 81 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to conduct a Breathing Rate and Pulse Rate accuracy validation comparing the NuraLogix AMC-SDK to the Reference devices, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda) and a standard ECG (GE Datex-Ohmeda) derived heart rate reference. This will be done by manually scoring the collected waveform for data analysis.

Conditions

  • Pulse Rate and Breathing Rate

Interventions

  • noninvasive and investigational NuraLogix AMC-SDKDevice

    The NuraLogix AMC-SDK is a noninvasive device that allows for real-time, remote measuring using facial recordings.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Breathing rate accuracy validationTime frame: 1-2 hours
  2. Pulse rate accuracy validationTime frame: 1-2 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Element Materials Technology

    Louisville, Colorado · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.